NYSE:CRLLife Sciences
Could Charles River (CRL) Using Locus Cell Tie-Up to Reframe Its Asia-Pacific Growth Strategy?
In March 2026, Locus Cell Co., Ltd. announced it had signed a Memorandum of Understanding with Charles River Laboratories to explore collaboration on CMC support, analytical testing, technical development, and related services for advanced therapy developers across Taiwan and the wider Asia-Pacific region.
This agreement links Charles River’s global biologics testing expertise with Locus Cell’s cell and gene therapy manufacturing platforms, highlighting a potential build-out of integrated...